Published in Ann Thorac Surg on January 01, 1994
Good outcomes from cardiac surgery in the over 70s. Heart (1999) 2.11
A decade's experience with quality improvement in cardiac surgery using the Veterans Affairs and Society of Thoracic Surgeons national databases. Ann Surg (2001) 1.45
Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries. J Am Coll Cardiol (2013) 0.87
The improving outcomes of coronary artery bypass graft surgery in Ontario, 1981 to 1995. CMAJ (1998) 0.86
The Society of Thoracic Surgeons National Database status report. Ann Thorac Surg (1994) 0.85
Left internal mammary artery usage in coronary artery bypass grafting: a measure of quality control. Ann R Coll Surg Engl (2006) 0.82
Emergency surgical revascularisation for coronary angioplasty complications. Br Heart J (1994) 0.82
Blood flow in the internal mammary artery after the administration of papaverine during coronary artery bypass grafting. Tex Heart Inst J (1996) 0.79
Intraoperative behavior of arterial grafts in the elderly and the young: a flowmetric systematic analysis. Heart Vessels (2008) 0.78
Operative and early results of coronary artery bypass grafting in female patients in different body mass indexes. J Cardiothorac Surg (2010) 0.78
Israeli women were at a higher risk than men for mortality following coronary bypass surgery. Eur J Epidemiol (1997) 0.77
The effect of not using an internal mammary artery as a conduit for coronary artery bypass grafting. Heart (2004) 0.75
A randomized comparison of flow characteristics of semiskeletonized and pedicled internal thoracic artery preparations in coronary artery bypass. J Cardiothorac Surg (2017) 0.75
Sex Differences in Mortality After CABG Surgery. Braz J Cardiovasc Surg (2015) 0.75
LIMA use in the STS database: a correction. Ann Thorac Surg (2002) 0.75
The UCSC Genome Browser Database. Nucleic Acids Res (2003) 32.84
Regulation of tumor antigen synthesis by simain virus 40 gene A. J Virol (1975) 9.93
Positive control of transcription initiation in bacteria. Annu Rev Genet (1984) 8.74
Isolation of the bacteriophage lambda receptor from Escherichia coli. J Bacteriol (1973) 7.67
Location of the maltose A and B loci on the genetic map of Escherichia coli. J Bacteriol (1966) 5.97
Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med (2001) 5.48
Maltose transport in Escherichia coli K12. A comparison of transport kinetics in wild-type and lambda-resistant mutants as measured by fluorescence quenching. Eur J Biochem (1976) 5.25
A role for mRNA secondary structure in the control of translation initiation. Nature (1982) 5.01
Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv (2001) 4.93
Use of gene fusions to study outer membrane protein localization in Escherichia coli. Proc Natl Acad Sci U S A (1977) 3.78
The adsorption of coliphage lambda to its host: effect of variations in the surface density of receptor and in phage-receptor affinity. J Mol Biol (1976) 3.75
Genetic analysis of the maltose A region in Escherichia coli. J Bacteriol (1969) 3.52
Escherichia coli mutants impaired in maltodextrin transport. J Bacteriol (1979) 3.51
Dominant constitutive mutations in malT, the positive regulator gene of the maltose regulon in Escherichia coli. J Mol Biol (1978) 3.46
Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet (1991) 3.37
[Existence in Escherichia coli K 12 of a common regulation of the biosynthesis of bacteriophage receptors and maltose metabolism]. Ann Inst Pasteur (Paris) (1967) 3.33
Pleiotropic mutations rendering Escherichia coli K-12 resistant to bacteriophage TP1. J Bacteriol (1980) 3.31
Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv (2001) 3.16
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics (1987) 3.03
Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience. Ann Thorac Surg (1994) 3.00
Structure of the malB region in Escherichia coli K12. I. Genetic map of the malK-lamB operon. Mol Gen Genet (1979) 2.99
[Phenotypic expression and genetic localization of mutations affecting maltose metabolism in Escherichia coli K 12]. Ann Inst Pasteur (Paris) (1967) 2.83
Structure of the malB region in Escherichia coli K12. II. Genetic map of the malE,F,G operon. Mol Gen Genet (1979) 2.83
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up. Leukemia (2012) 2.80
Impaired recognition memory in monkeys after damage limited to the hippocampal region. J Neurosci (2000) 2.77
Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet (2001) 2.70
Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood (2001) 2.61
Complementation studies in the maltose-A region of the Escherichia coli K12 genetic map. J Mol Biol (1971) 2.60
malB region in Escherichia coli K-12: characterization of new mutations. J Bacteriol (1974) 2.56
CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer. J Clin Oncol (1993) 2.49
Intergration of the receptor for bacteriophage lambda in the outer membrane of Escherichia coli: coupling with cell division. J Bacteriol (1975) 2.47
Mutations that affect lamB gene expression at a posttranscriptional level. Proc Natl Acad Sci U S A (1981) 2.46
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Mutations altering the cellular localization of the phage lambda receptor, an Escherichia coli outer membrane protein. Proc Natl Acad Sci U S A (1978) 2.37
Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet (1990) 2.33
Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med (1998) 2.31
The use of gene fusions to study the expression of malT the positive regulator gene of the maltose regulon. J Mol Biol (1979) 2.27
Hippocampectomy impairs the memory of recently, but not remotely, acquired trace eyeblink conditioned responses. Behav Neurosci (1995) 2.25
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24
Control of expression of the pyr genes in Salmonella typhimurium: effects of variations in uridine and cytidine nucleotide pools. J Bacteriol (1975) 2.24
[Maltodextrin phosphorylase of Escherichia coli]. Eur J Biochem (1967) 2.21
Sequence information within the lamB genes in required for proper routing of the bacteriophage lambda receptor protein to the outer membrane of Escherichia coli K-12. J Mol Biol (1982) 2.20
A technique for integrating any DNA fragment into the chromosome of Escherichia coli. Gene (1984) 2.11
Phosphoglucomutase mutants of Escherichia coli K-12. J Bacteriol (1971) 2.07
The enigma of myelin-associated growth inhibitors in spontaneously regenerating nervous systems. Trends Neurosci (1994) 2.06
Protein Ia and the lamB protein can replace each other in the constitution of an active receptor for the same coliphage. Proc Natl Acad Sci U S A (1978) 2.06
Colicin E2 release: lysis, leakage or secretion? Possible role of a phospholipase. EMBO J (1984) 2.02
Extracellular pullulanase of Klebsiella pneumoniae is a lipoprotein. J Bacteriol (1986) 2.02
A signal sequence is not sufficient to lead beta-galactosidase out of the cytoplasm. Nature (1980) 2.00
Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters. Leukemia (2009) 1.99
Dissociation between the effects of damage to perirhinal cortex and area TE. Learn Mem (2000) 1.97
Induction of enzymes involed in the catabolism of deoxyribonucleosides and ribonucleosides in Escherichia coli K 12. Eur J Biochem (1971) 1.97
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med (1998) 1.93
Mutations allowing growth on maltose of Escherichia coli K 12 strains with a deleted malT gene. Mol Gen Genet (1971) 1.92
Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.85
Alcohol dehydrogenase-negative mutants in Drosophila: defects at the structural locus? Genetics (1976) 1.84
On the significance of the retention of ligand by protein. Proc Natl Acad Sci U S A (1975) 1.83
Energy-coupling of the transport system of Escherichia coli dependent on maltose-binding protein. Eur J Biochem (1977) 1.83
Reversible interaction between coliphage lambda and its receptor protein. J Mol Biol (1975) 1.82
Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat (1993) 1.79
Characterization and expression of the structural gene for pullulanase, a maltose-inducible secreted protein of Klebsiella pneumoniae. J Bacteriol (1985) 1.78
Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am J Orthopsychiatry (1998) 1.78
Restriction map of the Escherichia coli malA region and identification of the malT product. J Bacteriol (1980) 1.77
Fractures of the spine in diffuse idiopathic skeletal hyperostosis. Clin Orthop Relat Res (1991) 1.76
Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA (1991) 1.75
Occurrence of the bacteriophage lambda receptor in some enterobacteriaceae. J Virol (1975) 1.74
Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat (1997) 1.74
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut (2005) 1.72
Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med (1996) 1.72
Characterization of Erwinia chrysanthemi extracellular proteases: cloning and expression of the protease genes in Escherichia coli. J Bacteriol (1987) 1.71
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler (2006) 1.70
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation (1995) 1.70
Magnetic resonance image-directed stereotactic neurosurgery: use of image fusion with computerized tomography to enhance spatial accuracy. J Neurosurg (1995) 1.70
The New Hampshire study of supported employment for people with severe mental illness. J Consult Clin Psychol (1996) 1.69
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet (1998) 1.67
Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg (1996) 1.67
Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol (1977) 1.66
A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials. Leukemia (2008) 1.64
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
Understanding physicians' intentions to withdraw from practice: the role of job satisfaction, job stress, mental and physical health. Health Care Manage Rev (2001) 1.63
Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci (2000) 1.62
Uridine phosphorylase from Escherichia coli. Physical and chemical characterization. Eur J Biochem (1977) 1.61
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci U S A (2001) 1.61
Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant (1994) 1.61
Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol (1994) 1.60
Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J Clin Oncol (1997) 1.60
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
The effect of nalidixic acid on the expression of some genes in Escherichia coli K-12. Biochem Biophys Res Commun (1975) 1.59
Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest (1991) 1.56
Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis (1993) 1.55
Essential and nonessential sequences in malPp, a positively controlled promoter in Escherichia coli. J Bacteriol (1985) 1.54
Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer (1999) 1.52
Catabolite repression in Escherichia coli mutants lacking cyclic AMP. Mol Gen Genet (1978) 1.50
Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study. J Rheumatol (2000) 1.50
Evidence for a coupling of synthesis and export of an outer membrane protein in Escherichia coli. EMBO J (1983) 1.50